Viscofan World You are in: The Viscofan Group EN | ES

The Viscofan Group




Czech Republic














United States



Asia & Oceania
Viscofan BioEngineering
Viscofan presents its Strategic Plan 2022-2025
Imagen Beyond


• The Plan seeks to strengthen leadership in the traditional business, in which Viscofan holds the global leadership, as well as to grow in new businesses oriented to nutrition and well-being, based on our experience of diversification in recent years

• The accumulated investment in the period will reach 425 million euros

• According to José Domingo de Ampuero y Osma, president of the company: "Viscofan has a clear vocation for growth. The new strategic plan foresees improvements in revenue, profitability, assets and return for shareholders, supported by a solid balance sheet that allows us to grow without compromising our financial stability."

Tajonar, February 24, 2022.- Viscofan presents today  its new purpose: "Reshaping food and wellbeing. For many, for long", which will guide its Strategic Plan for the period 2022-2025, after the success of its previous MORE TO BE plan, which included the period 2016-2021. With this new plan, the company intends to take advantage of its technology and global presence to contribute to access to basic food worldwide, a fundamental pillar of nutrition and well-being of people. All this with a long-term vision, generating a permanent impact over time.

With this new purpose, sustainability is positioned as a new strategic pillar and Viscofan expands its business range, from casingss to other new businesses linked to access to nutrition and well-being. In this way, two new business segments are created: Traditional Business (TB) for cellulosic, fibrous and collagen casings, and New Business (NB) that brings together the new activities of Viscofan including, among others, plant casings, functional solutions and products based on ingredients, mainly collagen protein, with application in the field of nutrition and bioengineering.

To comply with its plan, Viscofan will accelerate its growth with ambitious investments in productive capacity and technological renewal. Through this plan Viscofan will increase the capacity of collagen in China, Spain, Germany, Serbia and the USA to capture the growth that is taking place fundamentally in this technology. In addition, new cellulosic casing production technology will be installed in the U.S. taking advantage of the know-how acquired in the latest technological leaps made during the previous strategic plan.

Additionally, the group will now organize its market segmentation into four major areas: Europe, the Middle East and Asia; Asia Pacific, North and South America.

If the expected growth opportunities materialize, the Viscofan Group would reach a revenue figure in 2025 of 1,300 million euros (representing a growth of more than 330 million in the strategic period), with an EBITDA margin of 26% and with an accumulated investment in the period of 425 million euros.

The operational transformation of Viscofan will be carried out under four main axes: technology transfer, capacity increase, digitalization and the aforementioned sustainability. The cultural transformation will be carried out under the axes of action of diversity, safety and health, agile management, talent, motivation and commitment.

To meet the objectives of this ambitious plan, the Group's Senior Management has been reorganized. Within this new organization of the Senior Management led by the General Director, the General Directorates by region (EMEA, Asia Pacific, North and South America) and the General Directorate of New Business are created, and the rest of the Corporate Directorates (Financial Management, Operations Management, Commercial Management, R&D and Quality Management,  Human Resources Management, Legal Management, Strategy, Organization and Systems Management, Diversification Management and Investor Relations and Communication Management).


® Viscofan Group